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Summary 
 
 We determined the effects of supplemental 
L-carnitine on the insulin-like growth factor 
(IGF) system in porcine embryonic myoblasts 
(PEM) from gilts.  Forty gilts (BW = 303.6 lb) 
were allotted to 1 of 4 treatments that were 
arranged in a 2 × 2 factorial, with main effects 
of L-carnitine (0 or 50 ppm) and day of gesta-
tion (55 or 70).  All gilts were fed 3.86 lb/day 
and a top-dress containing either 0 or 50 ppm 
of L-carnitine, starting on the first day of 
breeding and continuing through the allotted 
gestation length.  At d 55 or 70 of gestation, 
fetuses were removed for isolation of PEM 
from the hind-limb muscles.  Real-time quan-
titative PCR was used to determine growth 
factor messenger RNA (mRNA) expression in 
cultured PEM at 72-, 96-, 120-, and 144-h af-
ter plating.  Flow cytometry was used to ana-
lyze percentage of myogenic cells with a 
myoblast/myotube-specific monoclonal anti-
body 5.1H11, and for determination of cell 
cycle stage.  There was no treatment differ-
ences (P>0.10) for the expression of IGF-I, 
IGF-II, or IGFBP-5 mRNA levels.  But PEM 
isolated from fetuses collected from gilts fed 
diets with L-carnitine had lower (P = 0.08) 
IGFBP-3 mRNA levels, compared with levels 
in  the controls.  Myoblasts isolated from fe-
tuses from gilts fed diets with added L-
carnitine had greater (P = 0.09; 8.8%) 5.1H11 
monoclonal antibody attachment, compared 
with the controls, after 72 hours in culture 
(91.8% vs. 87.4%).  Although not significant 
(P = 0.31), the total number of PEM in the S 
phase of the cell cycle was 4.7% greater in 
PEM collected from fetuses obtained from 
gilts fed diets with L-carnitine, compared with 
numbers from the control-fed gilts (37.5% vs. 
34.2%).  These data suggest that L-carnitine 
influences the IGF system, stage of the cell 
cycle, and recognition of muscle development, 
resulting in enhanced proliferation and de-
layed differentiation of PEM.   
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Introduction 
 
 The addition of L-carnitine to gestation 
diets has positive effects on sow reproductive 
performance.  Specifically, providing supple-
mental L-carnitine to gestating sows increases 
average pig weight and litter weight at birth.  
This may be due to L-carnitine’s role in β-
oxidation, glucose disposal, and carbohydrate 
metabolism.  Other researchers have alluded 
to the effect of L-carnitine on the insulin-like 
growth factor system.  
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 Insulin-like growth factors (IGF) and insu-
lin-like growth factor binding proteins 
(IGFBP) stimulate cellular proliferation and 
differentiation of myogenic cells.  These com-
ponents of the IGF system are involved in 
several aspects of fetal growth and develop-
ment, and seem to be modulators of muscle 
development in the pig fetus.  
 
 In previous data, we reported an increase 
in fetal weight at d 70 of gestation in fetuses 
collected from gilts fed diets with supplemen-
tal L-carnitine, and we have observed an in-
crease in IGF-I, IGFBP-3, and IGFBP-5 
mRNA expression in the endometrium of gilts 
fed diets containing supplemental L-carnitine.  
In addition, we observed a decrease in hepatic 
IGF-I expression in fetuses collected from 
gilts fed diets with supplemental L-carnitine.  
Changes in IGF-I, IGFBP-3, and -5 in the ma-
ternal endometrium and IGF-I in fetal hepatic 
tissue provide support for an altered maternal-
fetal exchange of IGF system components due 
to supplementation of L-carnitine to the gilt.  
This may or may not explain the increased 
weight of pigs born to dams fed supplemental 
L-carnitine. 
 
 During pregnancy, growth factors and 
binding proteins play a role in fetal muscle 
development in the pig.  Although data are 
limited, studies have observed decreased lev-
els of IGF-II, IGFBP-3, and myogenin in PEM 
collected from fetuses from sows fed supple-
mental L-carnitine up to d 55 of gestation.  
Further evidence to support enhanced prolif-
eration of porcine myogenic cells is the in-
crease in the cross-sectional area of the sem-
itendinosus, increased primary muscle fiber 
numbers, and a lower secondary:primary fiber 
ratio at birth in offspring of sows fed diets 
containing supplemental L-carnitine.  There-
fore, our experiment was designed to deter-
mine the effects of providing supplemental L-
carnitine to gestating gilts on fetal muscle de-
velopment in vitro by using real-time quantita-
tive polymerase chain reaction (PCR) tech-
niques and flow cytometry.  
Procedures 
 
 All animal procedures used in this study 
were reviewed and approved by the Kansas 
State University Animal Care and Use Com-
mittee. Forty gilts (PIC, Franklin, KY; L327 × 
1050; BW = 303.6 lb) were artificially in-
seminated (PIC; MQ 280) 12, 24, and 36 h 
after the onset of the second observed estrus.  
Gilts were randomly allotted to 1 of 2 dietary 
treatments and 1 of 2 harvesting dates (d 55 or 
70 of gestation), based on weight at breeding.  
All gilts were fed a corn-soybean meal gesta-
tion diet (Table 1) once daily (3.86 lb/day) and 
received a 50-g top-dress containing either 0 
(control, n = 30) or 88 mg (equivalent to ap-
proximately 50 ppm on an as-fed basis) of L-
carnitine (Carniking 10; 10% L-carnitine, 
Lonza Group, Inc., Allendale, NJ, n = 29) 
from d 1 to d 54 or 69 gestation.   
 
 Gilts were harvested on d 55 or 70 of ges-
tation.  Gilts were allowed ad libitum access to 
water until harvest.  Gilts were harvested by 
electrical stunning, followed by exsanguina-
tion.  A mid-lateral incision was made to gain 
access to the abdominal cavity.  The ovarian 
pedicles and uterine stump, at the level of the 
cranial cervix, were cut for removal of the 
uterus.  Once the uterus was removed, the 
number of fetuses was determined on both 
sides.   
 
 The hindlimb muscles from the right side 
of the fetus were aseptically excised, washed, 
minced with a scissor, and pooled for each of 
the gilts.  All cultures were maintained at 
37°C, 5% CO2, and 95% air in a water-
saturated environment.  After a 24-h attach-
ment period, the plates were rinsed three times 
with 2.5 mL of DMEM.  At 72, 96, 120, and 
144 h after plating, total RNA was isolated 
from the cells on the 29.26 cm2 plates (Abso-
lutely RNA Microprep kit, Stratagene, La 
Jolla, CA).  The concentration of total RNA 
was determined at an absorbance of 260 nm.  
TaqMan reverse transcription reagents and 
MultiScribe reverse transcriptase (Applied 
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Biosystems, Foster City, CA) were used to 
produce cDNA from 1 μg of total RNA.  Ran-
dom hexamers were used as primers in cDNA 
synthesis.   
  
Table 1.  Diet Composition Fed During Gesta-
tion (As-fed Basis)a
Item  Amount 
Ingredient, %   
   Corn  81.22 
   Soybean meal, 46.5%  14.55 
   Monocalcium phosphate, 21% P  2.03 
   Limestone  1.05 
   Salt  0.50 
   Vitamin premixb  0.25 
   Trace mineral premixc  0.15 
   Sow add packd  0.25 
  Total  100.00 
Calculated Analysis   
   Lysine, %  0.65 
   ME, Mcal/kg  3.27 
   Protein, %  13.7 
   Calcium, %  0.85 
   Phosphorus, %  0.75 
   Available P, %  0.48 
aGestation feeding levels of 1.75 kg/d, with a top-
dress providing either 0 or 50 ppm added L-
carnitine.   
bSupplied per kilogram of diet:  11,025 IU of vi-
tamin A, 1,654 IU of vitamin D3, 55.1 mg of nia-
cin, 44.1 IU of Vitamin E, 33.1 mg of pantothenic 
acid, 9.9 mg of riboflavin, 4.4 mg of vitamin K 
(menadione), and 0.04 mg of vitamin B12. 
cSupplied per kilogram of diet:  165 mg of Zn (ox-
ide), 165 mg of Fe (sulfate), 39.7 mg of Mn (ox-
ide), 16.5 mg of Cu (sulfate), 0.30 mg of I (as Ca 
iodate), and 0.30 mg of Se (as Na selenite).   
dSupplied per kilogram of diet:  551.3 mg of cho-
line, 15.2 mg pyridoxine, 1.65 mg of folic acid,
and 0.22 mg of biotin. 
 
 Real-time quantitative-PCR was used to 
measure the quantity of mRNA for IGF-I, 
IGF-II, IGFBP-3, and IGFBP-5 and 18S 
rRNA in total RNA isolated from cell cul-
tures.  Measurement of the relative quantity of 
cDNA was carried out by using TaqMan Uni-
versal PCR Master Mix (Applied Biosystems).  
Sequences for primers and probes for IGF-I, 
IGF-II, IGFBP-3, and IGFBP-5 are repre-
sented in Table 2.  Commercially available 
eukaryotic 18S rRNA primers and probes 
were used as an endogenous control (Applied 
Biosystems; Genbank Accession no. X03205).   
 
 Relative expressions of mRNA for IGF-I, 
IGF-II, IGFBP-3, and IGFBP-5 were normal-
ized to the 18S rRNA endogenous control by 
using the ∆-CT method, and were expressed in 
arbitrary units.   
 
 For analysis of myogenic cells, we ana-
lyzed muscle cell preparations by using a 
myoblast/myotube-specific monoclonal anti-
body 5.1H11 obtained from the Developmen-
tal Studies Hybridoma Bank (The University 
of Iowa, Iowa City, IA).   
 
 The statistical analysis for gene expression 
was performed as a repeated measure by using 
the MIXED Procedure of SAS.  Fixed effects 
of treatment, day of gestation, and hour after 
plating were included in the model, with hour 
after plating as the repeated measure.  Ken-
ward-Roger adjustment was used for the de-
grees of freedom.  Flow cytometric analysis 
was performed by using the MIXED Proce-
dure of SAS.  The model contained the effects 
of treatment, day of gestation, and their inter-
action.  Kenward-Roger was used to adjust the 
degrees of freedom. 
 
Results and Discussion 
 
 Primary mononucleated myoblasts or 
muscle cells are destined to have three specific 
roles.  They may differentiate into primary 
muscle fibers, promote secondary muscle fiber 
development, or may be reserved as a popula-
tion of satellite cells aiding in skeletal muscle 
hypertrophy in the post-natal animal.  The IGF 
system is instrumental in skeletal muscle de-
velopment, specifically muscle cell prolifera-
tion and differentiation.   
 
 In our study, we found IGF-I and IGFBP-3 
mRNA expression increased in PEM as day of 
gestation increased from day 55 to 70 (65% 
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and 50%, respectively; Table 3).  Insulin-like 
growth factor-I and IGFBP-3 play a role in 
proliferation and terminal differentiation of 
PEM.  As day of gestation increased from day 
55 to day 70 of gestation, IGF-I mRNA ex-
pression increased 70%, and IGFBP-3 mRNA 
expression increased 72%, in skeletal muscle 
tissue.  In our experiment, we found IGFBP-3 
mRNA expression was reduced at 96 h after 
plating, suggesting that the initiation of termi-
nal differentiation of PEM began at 96 h after 
plating.  In addition, IGF-I and IGF-II mRNA 
levels were found to be increased at 120 h af-
ter plating.  We found that levels of IGFBP-3 
mRNA were increased in the control gilts at 
120 h after plating.  Other researchers have 
found, at 120-h after plating, that IGFBP-3 
mRNA expression was reduced in differentiat-
ing porcine embryonic cell cultures.  The in-
crease in IGF-I and IGF-II mRNA levels at 
120 h and the reduced IGFBP-3 mRNA levels 
at 96 h that we observed confirm the roles of 
IGF-I, IGF-II, and IGFBP-3 mRNA in prolif-
eration and terminal differentiation of PEM.  
Therefore, we conclude that the reduced levels 
of IGFBP-3 mRNA we observed in the L-
carnitine cultures, compared with those of the 
controls, are a result of PEM increased prolif-
erative capacity, but delayed differentiation.  
This suggests that more nuclei may be avail-
able for muscle fiber development.   
 
 Data are limited on the effects of L-
carnitine on IGF system changes in skeletal 
muscle development during fetal growth.  In 
the current study, we found that mononucle-
ated myoblasts isolated from hindlimb mus-
cles of fetuses had changes in IGFBP-3 gene 
expression when their dams were fed diets 
with L-carnitine.  Specifically, IGFBP-3 gene 
expression decreased 48% when L-carnitine 
was added to the diets.   
 We used flow cytometry analysis to de-
termine if L-carnitine affected the percentage 
of PEM positive for the monoclonal antibody 
5.1H11 and the stage of the cell cycle in pro-
liferating myoblasts.  The PEM isolated from 
fetuses obtained from gilts fed diets contain-
ing supplemental L-carnitine had 4.7% greater 
adhesion of 5.1H11.  This indicates that the 
PEM isolated from fetuses from gilts fed diets 
with L-carnitine had a more enriched popula-
tion of myogenic cells.  This may suggest that 
L-carnitine has additional roles in fetal devel-
opment, although direct conclusions cannot be 
drawn.   
 
 Similar observations were noted for flow 
cytometric analysis of the percentage of cells 
in the S phase of the cell cycle.  Porcine em-
bryonic myoblasts collected from fetuses from 
gilts fed diets with supplemental L-carnitine 
had 8.8% more PEM in the S phase of the cell 
cycle. A fluorescence-activated cell sorter de-
termined this.  Mitosis, the process of nuclear 
division, contains four distinct cycles, of 
which, in the S phase, synthesis of DNA oc-
curs.  In our study, 37.5% of the population of 
PEM collected from the fetuses from the gilts 
fed supplemental L-carnitine were in the S 
phase, and only 34.2% of the control PEM 
were in the S phase. 
 
 Providing supplemental L-carnitine to ges-
tating gilts altered the IGF axis in PEM col-
lected from fetuses.  Specifically, we observed 
a decrease in IGFBP-3 mRNA expression in 
PEM collected from fetuses from gilts fed L-
carnitine.  Insulin-like growth factor binding 
protein-3 plays a role in terminal differentia-
tion of PEM.  We believe that providing sup-
plemental L-carnitine to the dam suppresses 
the expression of IGFBP-3 in PEM, therefore 
enhancing muscle proliferation and suppress-
ing differentation. 
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Table 2.  Primers and Probes Used for Real-time Quantitative PCR 
Gene 
Genbank  
Accession Number  Sequence 
IGF-I M31175 Forward TCTTCTACTTGGCCCTGTGCTT 
  Reverse GCCCCACAGAGGGTCTCA 
  Probe 6FAM-CCTTCACCAGCTCTGCCACGGC-TAMRA 
IGF-II X56094 Forward CCGGACAACTTCCCCAGATA 
  Reverse CGTTGGGCGGACTGCTT 
  Probe 6FAM-CCCGTGGGCAAGTTCTTCCGC-TAMRA 
IGFBP-3 AF085482 Forward AGCACGGACACCCAGAACTT 
  Reverse CGGCAAGGCCCGTATTC 
  Probe 6FAM-TCCTCTGAGTCCAAGCGCGAGA-TAMRA 
IGFBP-5 U41340 Forward GGCAGAGGCCGTGAAGAAG 
  Reverse CAGCTCCCCCCACGAACT 
  Probe 6FAM-CCGCAGAAAGAAGCTGACCCAGTCC-TAMRA 
 
 
 
Table 3.  Growth Factor Messenger RNA Levels in Porcine Embryonic Myoblasts at Day 55 of
Gestationa  
 Hour After Plating  
 72  96 120 144  
 L-carnitine, ppm  
Gene 0 50  0 50 0 50 0 50 SED 
   IGF-I 0.13 0.21 0.17 0.05 0.30 0.35 0.18 0.30 0.277-0.330 
   IGF-II 199.8 179.0 58.7 133.9 415.6 558.9 123.7 568.5 353.87-387.62 
   IGFBP-3 40.8 13.9 1.8 0.3 5.0 1.9 14.0 16.2 15.92-16.38 
   IGFBP-5 147.3 69.5 74.3 27.9 47.4 69.8 45.6 57.2 87.88-93.50 
aGene expression levels are expressed in arbitrary units (millions).   
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Table 4.  Growth Factor Messenger RNA Levels in Porcine Embryonic Myoblasts at Day 70 of
Gestationa  
 Hour After Plating  
 72  96 120 144  
 L-carnitine, ppm  
Gene 0 50  0 50 0 50 0 50 SED 
   IGF-I 0.42 0.29 0.22 0.41 0.87 1.01 0.65 0.98 0.277-0.298 
   IGF-II 862 41,127 599 41,017 3,655 42,280 634 41,508 29211-30,014 
   IGFBP-3 43.6 5.7 6.0 3.9 32.7 18.7 41.6 35.1 15.92-16.67 
   IGFBP-5 146.2 62.3 52.2 82.9 376.9 121.3 53.7 55.7 87.88-101.23 
a Gene expression levels are expressed in arbitrary units (millions).   
 
 
 
Table 5.  Statistical Analysis of Growth Factor Messenger RNA Levels in Porcine Embryonic 
Myoblasts at Day 55 and 70 of Gestationa
 Probability, P < 
 TRT Day Hour TRT × Day TRT × Hour Day × Hour TRT × Day × Hour  
   IGF-I 0.58 0.01 0.01 0.73 0.84 0.29 0.83 
   IGF-II 0.34 0.32 0.01 0.35 0.33 0.07 0.56 
   IGFBP-3 0.08 0.07 0.01 0.54 0.21 0.28 0.99 
   IGFBP-5 0.28 0.27 0.10 0.56 0.48 0.11 0.24 
 
 
 
Table 6.  Flow Cytometric Analysis 
 Day of Gestation  
 55 70   
 L-carnitine, ppmb  Probability, P < 
Item 0 50 0 50 SED Trtc Dayd Trt × Day 
5.1H11, % 84.1 89.4 90.8 94.2 2.92-3.63 0.09 0.20 0.77 
         
Cell cycle stage, %         
   G1 60.1 55.7 56.9 55.8 3.42-3.82 0.44 0.67 0.65 
   S 34.0 37.7 34.4 37.4 2.84-3.60 0.31 0.99 0.91 
   G2 6.01 7.29 8.72 7.38 1.74-1.95 0.99 0.45 0.48 
 
